Large Swedish cohort study finds delusional disorder, acute psychoses, psychosis NOS, and schizoaffective disorder are genetically distinct from SZ, BD, and MD.

Alembic Pharma receives USFDA approval for generic Paroxetine extended-release tablets to treat depression and anxiety ...

HealthDay News — Psilocybin-assisted therapy (PAT) shows long-term safety and efficacy for treating symptoms of major depressive disorder (MDD), according to a study published in the Journal of ...

I made sure I took care of my daughter and her needs, but due to my depression, I wasn’t taking care of myself.

If you live with both ADHD and depression, learn how to recognize symptoms, find support, and develop effective strategies ...

I think there is a misapprehension that those of us in the mental-health field who write self-help books do so from a clinical distance and without personal experience with the content that we present ...

The final approval by the US Food & Drug Administration (USFDA) is for the abbreviated new drug application (ANDA) of Paroxetine extended-release tablets of strengths 25 mg and 37.5 mg, Alembic ...

Skoltech scientists and their colleagues from other Russian medical research centers and mental health institutions have ...

Alembic Pharmaceuticals (Alembic) today announced that it has received final approval from the US Food & Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) Paroxetine Extended ...

Please provide your email address to receive an email when new articles are posted on . At day 43, lumateperone led to greater improvement vs. placebo on all metrics. Treatment-emergent adverse events ...